Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome.

Slides:



Advertisements
Similar presentations
Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Advertisements

Programmes and prospects for ovotechnology
Cancer and fertility: strategies to preserve fertility
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Diet and endometriosis risk: A literature review
Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS  Bulent O Yildiz, Gurkan Bozdag, Umit Otegen, Ayla Harmanci,
Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome  Qing Sang, Shaozhen Zhang,
Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria  M. Guo, Z.J.
Hatem Abu Hashim  Reproductive BioMedicine Online 
Donghong He, Fengyan Jiang  Reproductive BioMedicine Online 
Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial  Malin Nylander, Signe Frøssing, Helle V. Clausen,
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
MiR-483–5p and miR-486–5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome  Lin Shi, Shan Liu, Wanqiu.
Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance  Cindy Farquhar, Jane Marjoribanks,
RBM online: challenges ahead in scientific publishing
Cornelia van Zyl, Maretha J. Visser  Reproductive BioMedicine Online 
Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome  Qiong Wang, Lu Luo, Qiong Lei, Ming-Mei Lin, Xuan.
Amir Wiser, Einat Shalom-Paz, Jordana H
HDlive ultrasound images in assisted reproduction treatment
Gillian M. Lockwood  Reproductive BioMedicine Online 
Semra Kahraman, Zafer Nihat Candan  Reproductive BioMedicine Online 
Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of.
Why are reproductive cancers more common in nulliparous women?
Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis  Hester Pastoor, PhD Reinier Timman, PhD, Cora de Klerk,
K. Gersak, A. Veble  Reproductive BioMedicine Online 
Consecutive repeat miscarriages are likely to occur in the same gestational period  Junhao Yan, Sotirios H. Saravelos, Ning Ma, Caihong Ma, Zi-Jiang Chen,
Anthropometric indices to predict insulin resistance in women with polycystic ovary syndrome in China  Tingting Liu, Qiuyi Wang, Wei Huang, Jing Tan,
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Chief editor's 2017 annual report
Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment  Mert Kucuk, Fadime Doymaz, Bulent Urman  Reproductive.
Zehong Zhou, Rong Li, Jie Qiao  Reproductive BioMedicine Online 
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Polycystic ovary syndrome: analysis of the global research architecture using density equalizing mapping  Dörthe Brüggmann, Lea Berges, Doris Klingelhöfer,
Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis  Juan Gui, Rui-hao Wang  Reproductive.
Cross-border reproductive care: a review of the literature
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Mutational analysis of TOX3 in Chinese Han women with polycystic ovary syndrome  Yuqian Cui, Shigang Zhao, Han Zhao, Yue Lv, Mengru Yu, Yu Wang, Zi-Jiang.
The incidence of long heterochromatic polymorphism variants in infants conceived through assisted reproductive technologies  Andrew Wilson, Katherine.
Ronit Machtinger, Raoul Orvieto  Reproductive BioMedicine Online 
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction  Kathrine Birch Petersen, Nina Gros Pedersen, Anette.
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
P Colls, N Goodall, X Zheng, S Munné  Reproductive BioMedicine Online 
Is polycystic ovary syndrome a sexual conflict? A review
Polycystic ovary morphology: age-based ultrasound criteria
Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS)  F. Gonzalez,
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Pietro Gambadauro, Ramesan Navaratnarajah 
Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease  Suleyman Guven, S Caner Karahan,
Implication of apoptosis in sperm cryoinjury
Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance  Shimon Segal,
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study  Kok-Min Seow, Yieh-Loong Tsai, Chi-Chang.
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
How common is polycystic ovary syndrome in recurrent miscarriage?
Nadine M. P. Daan, Annemieke Hoek, Eva Corpeleijn, Marinus J. C
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years?  Kirsten Tryde Macklon, Erik Ernst, Anders Nyboe Andersen,
Programmes and prospects for ovotechnology
Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S
Nicole A. Huijgen, Yvonne V. Louwers, Sten P. Willemsen, Jeanne H. M
Paolo Moghetti, M.D.  Fertility and Sterility 
China’s model of egg donation is a policy lesson for Britain
Yakoub Khalaf, Susan Bewley, Peter Braude 
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?  Nadine M.P. Daan, M.D., Yvonne V.
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Fertility in cancer patients after cryopreservation of one ovary
Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate  Lobke M. Moolenaar, Marleen.
Presentation transcript:

Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis  J.P. Christ, M.N. Gunning, B.C.J.M. Fauser  Reproductive BioMedicine Online  Volume 35, Issue 4, Pages 480-483 (October 2017) DOI: 10.1016/j.rbmo.2017.06.020 Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Comparison of Rotterdam 2003 and Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS) 2014 guidelines for polycystic ovarian morphology when diagnosing polycystic ovary syndrome. Group C: Rott ‘03’ is equivalent to the new Non-PCOS group referenced in Table 1. All non-shaded regions represent Group D (original non-PCOS). Comparisons are made between Groups A (n = 157); B (n = 125); C (n = 72); and D (n = 50) in Table 1. 398 women had OA, 161 had HA, 112 met Rott 2003 PCOM criteria but not AEPCOS 2014 criteria, 223 met AEPCOS 2014 PCOM criteria. PCOS, polycystic ovary syndrome; HA, hyperandrogenism; OA, oligio-amenorrhea; Rott, Rotterdam; PCOM, polycystic ovarian morphology. Reproductive BioMedicine Online 2017 35, 480-483DOI: (10.1016/j.rbmo.2017.06.020) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions